Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Neal-Perry G, Cano A, Lederman S, Nappi RE, et al. Obstet Gynecol 2023 Mar 9. doi: 10.1097/AOG.0000000000005114.

Read + Share

Amedeo Smart

Independent Medical Education

Neal-Perry G, Cano A, Lederman S, Nappi RE, et al. Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Obstet Gynecol 2023 Mar 9. doi: 10.1097/AOG.0000000000005114.
PMID: 36897180